Veronica Kang

Dr. Kang is a highly effective molecular biochemist with B2B expertise. She has built on her research experiences in biochemistry, molecular biology, cell biology, and protein production with revenue generating business development sales & marketing experience in API drug substance cGMP manufacturing and In Vitro Diagnostics. She has provided technical troubleshooting and strategic planning, closed contracts, performed market analysis, and facilitated new market penetration. Dr. Kang has held executive positions in Business Development at Senn Chemicals (Switzerland), Ferro Pfanstiehl Laboratories, and IRIX Pharmaceuticals. She was a Product Development Manager/ Senior Scientist at Echelon Biosciences/University of Utah and Post-doctoral Scholar at NIH/NIAID Laboratory of Immunoregulation. Dr. Kang has a PhD from Georgetown University.